31st Mar 2010 17:00
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 30 March 2010, the interest of David Brennan, a Director of the Company, in AstraZeneca ordinary shares, changed as detailed below. The change in interest relates to the vesting of a previously announced award made in March 2007 under the AstraZeneca Performance Share Plan whereby, following the application of performance measures specified at the time of grant, Mr Brennan has now become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.
|
Name of Director |
Gross Shares Awarded |
Shares Lapsed |
Shares Vested |
Shares Withheld |
Net Shares Received |
Market Price on Vesting |
|
David R Brennan |
107,051 |
23,552 |
83,499 |
34,235 |
49,264 |
2980p |
Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share.
As a result of this transaction, Mr Brennan now has an interest in 458,926 Ordinary Shares and 77,946 AstraZeneca ADSs, which together represent approximately 0.04% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
31 March 2010
Related Shares:
Astrazeneca